blindness from tirzepatide and Semaglutide or Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes Ophthalmic Complications Observed After Use – Comparative ocular outcomes of tirzepatide

doi: 10.1016/j.bone.2020.115553 27 HansenMSSeKChristensenLLFernandez-GuerraPHansenNWWyattRAet al

They can assess whether the treatment is causing hair loss and suggest adjustments, treatments or supplements to address the issue

Eli Lilly has emphasized its commitment to accessibility, offering patient support programs, including a lower-cost vial option, to help ease financial barriers

Genome-wide linkage and association study identifies novel genes and pathways implicated in polycystic ovarian syndrome

The FDA requires a black-box warning on all GLP-1 products because of this finding, even though human evidence remains limited

In case you missed it